News
July 26, 2019

Regenstrief researcher discusses care processes that improve outcomes for TIA and minor stroke patients

Dawn Bravata on JAMA Network Open

Dr. Dawn Bravata interviewed on JAMA Network Open Live

Regenstrief Institute’s Dawn Bravata, M.D., an expert in stroke care, spoke to JAMA editors about her recent paper published in JAMA Network Open. The study examined the care processes associated with mortality and recurrent stroke in patients with TIA and non-severe strokes.

Dr. Bravata’s team examined 28 processes of care and defined six processes as “without-fail care” because they have been found to be effective in past studies and should be routinely available at most facilities. Those processes were: brain imaging, carotid artery imaging, hypertension medication intensification, high-moderate potency statin, antithrombotics, and anticoagulation for atrial fibrillation. Patients who received all of the processes for which they were eligible were classified as passing the “without-fail care” measure.

The study looked at more than 8,000 veterans who received VA care in an emergency or inpatient setting from October 2010 to September 2011.

The findings of the paper concluded that without-fail care — including the six readily available processes — was associated with lower odds of death but not lower recurrent stroke rates. Dr. Bravata and her team recommend healthcare systems prioritize patients with TIA or non-severe stroke and provide them with all the without-fail care processes they are eligible for.

Dr. Bravata discussed the study and its implications, answering questions from the hosts of JAMA Network Open Live. Watch the clips.

Study background and method

The key finding

The difference in quality of care for TIA and stroke

The VA has improved its quality of care since 2010/2011. What is the relevance of this data?

Seeing a neurologist within 24 hours is linked with better mortality rates

Neurologists and hypertension management

The processes are associated with lower risk of mortality but not stroke reduction

Watch the entire interview:

Read the entire paper

In addition to Regenstrief, Dr. Bravata is a core investigator at the Veterans Affairs Health Services Research and Development Center for Health Information and Communication, Richard L. Roudebush VA Medical Center, co-principal investigator, VA HSR&D Stroke Quality Enhancement Research Initiative, and a professor at Indiana University School of Medicine.

Related News

Dr. Shaun Grannis on Monkeypox

Dr. Shaun Grannis on Monkeypox

What should Hoosiers know about Monkeypox and the increasing cases in the state of Indiana? Regenstrief Vice President for

Dawn Bravata, MD

COVID did not affect stroke patient care quality or outcomes in nation’s largest healthcare system

In one of the first studies to investigate the overall quality of care and outcomes of stroke care for

Richard Holden and Noll Campbell

Helping the Helpers: Leveraging information technology to support caregiver medication management for the millions of individuals who live with dementia

Innovative methodology involves caregivers as co-designers not simply informants and includes virtual component More than 21 million people provide

Thankham Thyvalikakath

Linking medical and dental records in health information exchanges could improve dental patient safety, preventive care, and treatment outcomes

New $2.4 million NIH award supports efforts to go beyond current inefficient, paper-based approach to data sharing Dental professionals